Sanofi Consumer Healthcare Intrinsic Value
Sanofi Consumer Healthcare intrinsic value. Sanofi Consumer Healthcare (SANOFICONR) median intrinsic value is ₹1596.65 from 9 valuation models (range ₹751–₹2541), vs current price ₹3752.70 — -57.5% downside (Trading Above Calculated Value), margin of safety -100.0%. Read SANOFICONR dividend payout details for the complete payout history and dividend yield track record.
SANOFICONR Valuation Methods Summary — DCF, Graham Number & P/E
Sanofi Consumer Healthcare intrinsic value across 9 models vs current price ₹3752.70 — upside/downside and value range per method. Compare with Sanofi Consumer Healthcare value estimation to assess whether the stock is under or overvalued.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹2541.00 | ₹2032.80 - ₹3049.20 | -32.3% | EPS: ₹115.50, Sector P/E: 22x |
| Book Value Method | asset | ₹750.54 | ₹675.49 - ₹825.59 | -80.0% | Book Value/Share: ₹166.96, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹1125.81 | ₹1013.23 - ₹1238.39 | -70.0% | Revenue/Share: ₹421.30, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹1617.39 | ₹1455.65 - ₹1779.13 | -56.9% | EBITDA: ₹372.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹1501.08 | ₹1200.86 - ₹1801.30 | -60.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹1596.65 | ₹1436.99 - ₹1756.32 | -57.5% | EPS Growth: 17.3%, Fair P/E: 13.8x |
| Growth Adjusted P/E | growth | ₹1862.44 | ₹1676.20 - ₹2048.68 | -50.4% | Revenue Growth: 15.0%, Adj P/E: 16.1x |
| ROE Based Valuation | profitability | ₹1876.35 | ₹1688.71 - ₹2063.99 | -50.0% | ROE: 69.3%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹1125.81 | ₹1013.23 - ₹1238.39 | -70.0% | EPS: ₹115.50, BVPS: ₹166.96 |
SANOFICONR Intrinsic Value vs Market Price — All Valuation Models
Sanofi Consumer Healthcare fair value range ₹751–₹2541 vs current market price ₹3752.70 across 9 valuation models. For current market price and key ratios, visit Sanofi Consumer Healthcare share price chart.
SANOFICONR Intrinsic Value Analysis — Undervalued or Overvalued?
Sanofi Consumer Healthcare median intrinsic value ₹1596.65, current price ₹3752.70 — Trading Above Calculated Value by 57.5%, margin of safety -100.0%.
What is the intrinsic value of SANOFICONR?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Sanofi Consumer Healthcare (SANOFICONR) is ₹1596.65 (median value). With the current market price of ₹3752.70, this represents a -57.5% variance from our estimated fair value.
The valuation range spans from ₹750.54 to ₹2541.00, indicating ₹750.54 - ₹2541.00.
Is SANOFICONR undervalued or overvalued?
Based on our multi-method analysis, Sanofi Consumer Healthcare (SANOFICONR) appears to be trading above calculated value by approximately 57.5%.
SANOFICONR Financial Health — Key Ratios vs Industry Benchmarks
Sanofi Consumer Healthcare financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 14.11 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 69.3% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 37.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.77x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
SANOFICONR Cash Flow Quality — Operating & Free Cash Flow
Sanofi Consumer Healthcare operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹175 Cr | ₹175 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹439 Cr | ₹439 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |